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Background: Playing a strategic role in the host immune function, the intestinal microbiota has been recently
hypothesized to be involved in the etiology of atopy. In order to investigate the gastrointestinal microbial ecology
of atopic disease, here we performed a pilot comparative molecular analysis of the faecal microbiota in atopic
children and healthy controls.
Results: Nineteen atopic children and 12 healthy controls aged 4–14 years were enrolled. Stools were collected
and the faecal microbiota was characterized by means of the already developed phylogenetic microarray platform,
HTF-Microbi.Array, and quantitative PCR. The intestinal microbiota of atopic children showed a significant depletion
in members of the Clostridium cluster IV, Faecalibacterium prausnitzii, Akkermansia muciniphila and a corresponding
increase of the relative abundance of Enterobacteriaceae.
Conclusion: Depleted in key immunomodulatory symbionts, the atopy-associated microbiota can represent
an inflammogenic microbial consortium which can contribute to the severity of the disease. Our data open
the way to the therapeutic manipulation of the intestinal microbiota in the treatment of atopy by means of
pharmaceutical probiotics.Background
Atopic diseases are chronic inflammatory disorders
caused by an aberrant T-helper (Th2)-type immune re-
sponse against common and innocuous environmental
antigens [1]. The elaboration of cytokines, such as inter-
leukin (IL)-4, IL-13 and IL-5, can contribute to disease
induction [2]. During the past decades the prevalence of
atopic diseases among children in the western world has
dramatically increased [2]. Too fast for any possible shift
in genetic constitution, environmental changes asso-
ciated with the western lifestyle are believed to be
involved [3,4]. The human intestinal microbial commu-
nity has been indicated as a key factor to interpret the
impact of the western lifestyle on the etiology of atopic
diseases [3-7]. The intestinal microbiota is extremely
plastic in response to diet and environmental factors
and, at the same time, governs many aspects of the
immune function throughout the body [8]. Thus, the* Correspondence: marco.candela@unibo.it
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reproduction in any medium, provided the orhypothesis that specific western lifestyle-driven dysbioses
of the human intestinal microbiota are involved in the
bloom of atopy in western children has been advanced.
The human intestinal microbiota consists of a total
amount of 1014 microbial cells differentiated in more
than 500 different species [9]. Showing a tremendous
metabolic potential, this versatile microbial “organ”
exerts a role of primary importance for our metabolism.
Recently, the strategic role of the intestinal microbiota
in the development, education and functionality of the
human innate and adaptive immune system has been
recognized [7,10]. According to Gaboriau-Routhiau
et al. [11], specific members of the intestinal microbial
community exert an active role in the modulation of a
striking range of T cell functions, such as Th17, Th1,
Th2 and regulatory cell phenotype (T regs). Having a
profound impact on the overall human immune status,
perturbations of the intestinal microbiota have been
implicated in the development and progression of in-
flammatory diseases, such as inflammatory bowel dis-
eases (IBD), autoimmune disorders, allergy and type II
diabetes [12,13].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tinal microbiota in the education of the human immune
system to tolerance [5], culture-independent perspective
studies have been carried out to determine whether spe-
cific microbiota dysbioses in the early life could affect
the subsequent manifestation and sensitization of atopic
diseases. In the Lifestyle and Genetic Constitution
(KOALA) Birth Cohort Study – an extensive epidemio-
logical study with involved 957 infants from Netherlands
aged 1 month – the presence of Escherichia coli and
Clostridium difficile in stools has been associated with a
higher risk to develop eczema [14]. Even if the health-
promoting microbiota components Bifidobacterium and
Lactobacillus have been suggested as possible protective
factors against the risk to develop atopy [15,16], no
differences in the prevalence of these probiotic genera
between infants with and without allergic disorders have
been detected [3,14,17,18]. More recently, two perspec-
tive surveys of the intestinal microbiota in Danish and
Swedish infants have been carried out with a longitu-
dinal approach, sampling the faecal microbiota at differ-
ent time points during the first year of life [19,20]. Based
on denaturing gradient gel electrophoresis (DGGE) and
16S rDNA 454-pyrosequencing, respectively, these
robust and extensive studies proved that the low bacter-
ial diversity in the early life, rather than the prevalence
of a specific bacterial taxon, is associated with an
increased risk of subsequent atopic disease, reinforcing
the “old friend hypothesis” [21]. According to this the-
ory, the western lifestyle caused the disappearance of key
bacterial groups from the intestinal microbiota, which
are essential to prime the physiology of our immune sys-
tem. The lack of these “old friends” during the perinatal
period led to an immune system incline to inappropriate
activation, which is a characteristic of the emerging
chronic inflammatory diseases in the western world.
Even if the role of the intestinal microbiota in the pre-
disposition to develop atopy in infancy has been
accepted, to our knowledge, only few case–control cul-
ture-independent studies of the gastrointestinal micro-
bial ecology in atopic diseases have been carried out.
However, by modulating the immune status throughout
the body [8], an inflammogenic gut microbial community
in atopic subjects could significantly contribute to the se-
verity of the disease. In this perspective we performed a
pilot case–control study of the atopy-associated dysbiosis of
the intestinal microbiota in atopic children. Since from
birth to weaning the infant intestinal microbiota is an ex-
tremely dynamic entity, which continuously fluctuates in
response to factors of environmental and endogenous ori-
gin [22], we enrolled children aged> 2 years, charac-
terized by a relatively stable adult-like intestinal
microbial community [23]. In particular, the faecal
microbiota of 19 atopic children and 12 healthycontrols aged 4–14 years was characterized by means
of the previously developed phylogenetic microarray
platform High Taxonomic Fingerprint (HTF)-
Microbi.Array [24] and quantitative PCR (qPCR).
Integrated of an additional probe pair for Akkerman-
sia muciniphila, the HTF-Microbi.Array platform
detects up to 31 intestinal bacterial groups and cov-
ers up to 95% of the human intestinal microbiota
[25]. For our study faeces were selected since they
represent the only realistic and reliable sample for a
non-invasive study of the human intestinal
microbiota.
Methods
Subjects enrolled and study groups
We enrolled 19 children (referred as atopics throughout
the paper) with clinical diagnosis of allergy (rhinitis,
asthma, grass pollen sensitization, allergic atopic derma-
titis, oral allergy syndrome, cow’s milk allergy) and
encountering all the following criteria: (i) delivered nat-
urally at term, (ii) breast fed for at least 3 months, (iii)
aged between 4 and 14 years, (iv) no acute diseases for
at least 2 weeks, (v) no antibiotic treatment in the last
3 months. In particular, 17 children presented allergic
rhinitis, in 4 cases associated with asthma. Atopic
dermatitis was observed in 8 cases of which 6 associated
with rhinitis and inhalant sensitization and 1 with food
allergy (Table 1). During the visit the children underwent
a clinical evaluation and skin prick test for main food or
inhalant allergens. Total and specific IgE determination
was performed when clinically necessary. Fresh stool
samples were collected within 3 days. As controls, 12
non-allergic children who encountered the same criteria
above described but without family history of atopy were
enrolled. All the children were routinely followed by the
Paediatric Oncology and Haematology Unit Lalla Seràgnoli,
Sant’Orsola-Malpighi Hospital, University of Bologna.
Parents provided a written informed consent. Approval by
the Ethics Committee of the Sant’Orsola-Malpighi Hospital
was not needed for this study.
Allergometric tests
Skin prick tests were performed following established
guidelines [26]. The following allergens were tested: cow’s
milk, egg, soy bean, wheat, peanut, codfish, grass pollen,
Dermatophagoides pteronyssinus, Dermatophagoides fari-
nae, and cat dander. Other allergens were tested on the
basis of the child’s history. Data of the skin prick tests were
used to determine the presence of atopic sensitization in
the definition of allergic or non-allergic atopic dermatitis.
The determination of total serum IgE was performed by
ELISA test; the values were assumed as normal or increased
in comparison with the ones from children of the same age
group [27]. The determination of specific IgE was
Table 1 Allergic profile of the 19 atopic children enrolled
in the study
Clinical diagnosis of allergy
Sample ID RCa Ab GPSc ADd OASe CMAf
A1 √ √ √ √
A2 √ √ √
A3 √ √
A4 √ √ √
A5 √ √ √
A6 √ √ √ √
A7 √ √ √
A8 √ √ √
A9 √ √ √ √ √
A10 √ √ √
A12 √ √ √
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http://www.biomedcentral.com/1471-2180/12/95performed by UNICAP 1000 (Phadia) in all patients for the
following allergens: cow’s milk, egg, soy bean, wheat, pea-
nut, codfish, Bermuda grass, timothy grass, D. pteronyssi-
nus, D. farinae, and cat dander. Other allergens were tested
on the basis of the child’s history.DNA extraction and polymerase chain reaction (PCR)
Total DNA from faecal material was extracted using
QIAamp DNA Stool Mini Kit (Qiagen) according to the
modified protocol reported by Candela et al. [24]. Final
DNA concentration was determined using NanoDrop
ND-1000 (NanoDrop Technologies). PCR amplifications
were performed with Biometra Thermal Cycler T
Gradient (Biometra). The 16 S rRNA gene was amplified
using universal forward primer 27 F and reverse primer
r1492, following the protocol described by Candela et al.
[24]. PCR products were purified by using the Wizard SV
gel and PCR clean-up System kit (Promega), eluted in
20 μl of sterile water and quantified with the DNA 7500
LabChip Assay kit and BioAnalyzer 2100 (Agilent Tech-
nologies). All the oligonucleotide primers used for PCRreactions and probe pairs employed for the array con-
struction were synthesized by Thermo Electron.HTF-microbi.Array analysis
The HTF-Microbi.Array utilized in this study is based on
the Ligase Detection Reaction-Universal Array (LDR-UA)
approach [28] and enables specific detection and quantifi-
cation of the 16 S rRNA from 31 phylogenetically related
groups of the human intestinal microbiota (Additional file
1). The original HTF-Microbi.array [24] was updated to
include a probe for the detection of A. muciniphila. The
new probe was designed and validated as reported by Can-
dela et al. [24] (Additional file 2). Sequences of the entire
probe set of the HTF-Microbi.Array are reported in Add-
itional file 3. Slide chemical treatment, array production,
LDR protocol and hybridization conditions were carried
out as previously reported [28,29] with probe annealing
set at 60°C. The LDRs were carried out in a final volume
of 20 μl with 50 fmol of PCR product. Two hundred and
fifty fmol of synthetic template (5’-AGCCGCGAACAC-
CACGATCGACCGGCGCGCGCAGCTGCAGCTTGCT
CATG-3) were used for normalization purposes. All HTF-
Microbi.Array experiments were performed in independ-
ent duplicates.Data analysis
All arrays were scanned and processed according to the
protocol and parameters already described by Candela
et al. [24]. Fluorescence intensities (IF) were normalized
on the basis of the synthetic ligation control signal: (a)
outlier values (2.5-fold above or below the average) were
discarded; (b) a correction factor was calculated in order
to set the average IF of the ligation control to 50000
(n = 6); (c) the correction factor was applied to both the
probes and background IF values. Reproducibility of the
experiments was assessed by calculating Pearson’s cor-
relation of the fluorescence signals between the two
replicates. LDR experiments showing a Pearson’s correl-
ation coefficient <0.95 were repeated. Mean data from
two replicated experiments were obtained and utilized
for principal component analysis (PCA), box plot ana-
lysis and calculation of the probe relative IF contribu-
tion. Non-parametric Kruskal-Wallis test was used to
determine whether the contribution of each bacterial
group was significantly different between atopics and
controls. Two-sided t-test was applied to evaluate
whether the relative percentage contribution of each
bacterial group was significantly different between the
two groups. Correlation between variables was
computed by Spearman rank correlation coefficient.
Statistical analyses were performed by using Canoco
package for Windows [30] and the R statistical software
(www.r-project.org).
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qPCR was carried out in a LightCycler instrument
(Roche). Quantification of the 16 S rRNA gene of A. muci-
niphila, Faecalibacterium prausnitzii, Enterobacteriaceae,
Clostridium cluster IV, Bifidobacterium and Lactobacillus
group was performed with the genus-, group- or species-
specific primers reported in Table 2. SYBR Green I fluoro-
phore was used to correlate the amount of PCR product
with the fluorescent signal. For quantification, standard
curves were generated with known amounts of pCR2.1
(Invitrogen)-cloned 16 S rRNA gene from A. muciniphila
(DSM22959), F. prausnitzii (DSM17677), E. coli
(ATCC11105), Clostridium leptum (DSM753), Bifidobac-
terium animalis subsp. lactis (BI-07) and Lactobacillus
acidophilus (LA-14). Amplification was carried out in a
20 μl final volume containing 100 ng of faecal DNA,
0.5 μM of each primer and 4 μl of LightCycler-FastStart
DNA Master SYBR Green I (Roche). Amplifications were
done under the following conditions: (i) starting preincu-
bation at 95°C for 10 min; (ii) amplification including 35
cycles of 4 steps each at the temperature transition rate of
20°C/s: denaturation at 95°C for 15 s, annealing at the ap-
propriate temperature (Table 2) for 20 s, extension at 72°C
for 30 s, and fluorescence acquisition at the appropriate
temperature (Table 2) for 5 s; (iii) melting curve analysis.
Results
Faecal microbiota profile of atopic children and healthy
controls
The faecal microbiota of 19 atopic children and 12
healthy controls living in Italy was characterized byTable 2 Primer sets used for the 16S rRNA gene quantificatio
Clostridium cluster IV, Bifidobacterium and Lactobacillus group
acquisition temperature are also reported
Target
microorganism
Primer set Sequence (5' to














Lactobacillus group Lac1 AGCAGTAGGGAATC
Lac2 ATTYCACCGCTACAmeans of the HTF-Microbi.Array platform (Additional
files 4 and 5) [24]. Hybridization experiments were per-
formed in two replicates. Pearson’s correlation coeffi-
cients ranging from 0.95 and 0.99 were achieved
between the two replicates, proving the high reproduci-
bility of the phylogenetic profiles obtained by the HTF-
Microbi.Array platform. A PCA of the fluorescence sig-
nals from atopics and controls was carried out. The
diagnosis of atopy was considered as a dummy environ-
mental variable. As shown in Figure 1A, the principal
components PC2 and PC3, which collectively repre-
sented only a minor fraction of the total variance (9.7%),
resulted in the separation of samples according to the
health status. In order to identify the bacterial lineages
showing differences in abundance between atopics and
controls, probe fluorescence signals obtained from the
HTF-Microbi.Array in atopics and controls were com-
pared by box plot analysis (Additional file 6). Probes
showing P< 0.3 are represented in Figure 1B. Atopic
children showed a tendency towards reduction of A.
muciniphila, F. prausnitzii et rel. and Ruminococcus
bromii et rel. (Clostridium cluster IV), and Clostridium
cluster XIVa, and were enriched in Enterobacteriaceae,
Bacillus clausii and Veillonella parvula.
On the basis of the HTF-Microbi.Array fluorescence
data, the relative contribution of the major phyla in ato-
pics and controls was calculated (Figure 2). At high
taxonomic level, atopics and controls showed a compar-
able overall phylogenetic composition of the faecal
microbiota. Indeed, their microbiota resulted largely
dominated by Bacteroidetes and Firmicutes, whichn of A. muciniphila, F. prausnitzii, Enterobacteriaceae,










GGGAC 349 63 88 [31]
CAGAT
GATTAG 199 67 85 [32]
CCTCC
GAAGAAG 195 63 87 [32]
GCTTGC
GGG 588 60 85 [33]
CGTA
GATG 523 60 90 [34]
GGAA













P = 0.24 2.0=P21.0=P180.0=P
980.0=P12.0=P P = 0.068 
6
Figure 1 Analysis of the HTF-Microbi.Array fluorescence signals. A: PCA of the HTF-Microbi.Array fluorescence signals. Atopy or health status
were considered as dummy environmental variables (green triangles) and indicated as atopic and control, respectively. Atopic subjects and
healthy controls are indicated by gray circles and red squares, respectively. Second and third ordination axes are plotted showing 6.4% and 3.3%
of the total variability in the dataset, respectively. B: Comparison of the HTF-Microbi.Array probe fluorescence signals between atopics and
controls. Only probes showing a different trend between the two groups (P< 0.3) are shown.
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community. With a relative abundance ranging from 1
to 5%, Fusobacteria, Actinobacteria and Proteobacteria
were sub-dominant components. However, focusing at
lower taxonomic level, significant differences in the rela-
tive contribution of certain microbial groups were
detected. In particular, atopics were characterized by a
lower relative contribution of members of the Clostrid-
ium cluster IV (atopics, 20.9% - controls, 28.7%;
P= 0.01) and a concomitant relative increase in Entero-
bacteriaceae (atopics, 2.4% - controls, 1.2%; P= 0.009)
and Fusobacteria (atopics, 1.9% - controls, 1.2%;
P= 0.001).
The abundance of F. prausnitzii, A. muciniphila,
Enterobacteriaceae, Clostridium cluster IV, Bifidobacter-
ium and Lactobacillus group in the faecal microbiota of
atopics and controls was investigated by qPCR analysis
of the 16 S rRNA gene. As reported in Table 3, respectto healthy controls, atopics were significantly depleted in
F. prausnitzii, A. muciniphila and members of the Clos-
tridium cluster IV, and tended to be depleted in Bifido-
bacterium and enriched in Enterobacteriaceae.Correlation among faecal microbiota, diagnosis of allergy
and total IgE
In order to investigate whether the profile of the faecal
microbial community of atopics correlated with their al-
lergy profile (Table 1), a PCA of the HTF-Microbi.Array
fluorescence signals from atopics was carried out. PCA
was performed by considering the types of allergic re-
sponse as dummy environmental variables. No separ-
ation of the atopic children according to the specific
diagnosis of rhinitis, asthma, grass pollen sensitization,
allergic atopic dermatitis, oral allergy syndrome and
cow’s milk allergy was obtained, proving that the atopy-
Figure 2 Relative contribution of the principal intestinal microbial groups in the faecal microbiota of atopics and controls.
For each HTF-Microbi.Array probe, the relative fluorescence contribution was calculated as percentage of the total fluorescence. Sub-probes were
excluded. Data represent the mean of the probe relative fluorescence contribution in atopics (n = 19) and controls (n = 12). P values derive from a
two-sided t-test.
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ent of the specific atopic outcome (data not shown).
In a subset of 10 atopy cases with clinical relevance
the total serum IgE levels were determined. Total IgE
ranged from 138 to 855 ku/L (geometric mean: 326 ku/
L), a value above the normal for age [27]. In order to in-
vestigate whether in this subset of 10 atopics IgE corre-
lated with the relative abundance of a specific microbial
group in the faeces, Spearman rank correlation coeffi-
cients between the probe relative fluorescence signals
and the IgE levels were calculated. According to our data
no significant correlation was determined. However, a
tendency towards an inverse correlation with IgE was
obtained for L. casei et rel. (ρ= 0.52; P= 0.100), while
Clostridium cluster IX abundance tended to be positively
correlated with total IgE (ρ= 0.60; P= 0.073) (Figure 3).
Discussion
In the present paper we combined two culture-inde-
pendent molecular approaches, HTF-Microbi.Array and
qPCR, for a pilot characterization of the atopy-asso-
ciated dysbiosis of the intestinal microbiota in 19 atopic
children living in Italy. At high phylogenetic level both
atopics and controls showed a comparable overall micro-
biota profile where Firmicutes and Bacteroidetes consti-
tuted the two dominant divisions. However, focusing at
lower taxonomic level, the intestinal microbiota of atopic
children was characterized by a significant depletion in
members of the Clostridium cluster IV, F. prausnitzii, A.
muciniphila and a corresponding increase of the relative
abundance of Enterobacteriaceae.In a case–control DGGE-based study of the faecal
microbiota from 20 allergic and 20 non-allergic 5-year-old
Estonian children, Stsepetova et al. [36] reported a less di-
verse composition in the faecal microbiota from atopic
children but, according to the Authors, no bacterial tar-
gets could distinguish infants with or without atopy. How-
ever, the DGGE-based approach allowed to consider only
the dominant fraction of the intestinal microbiota,
remaining blind with respect to the whole phylogenetic
complexity of the ecosystem. In an elegant 16 S rDNA
pyrosequencing-based dynamic study, Hong et al. [37]
addressed the differences in the microbiota succession be-
tween 3 infants with and 4 without eczema over four time
points until 24 months of age. Even if age was shown to
be the dominant factor mediating microbiota changes,
matched by age eczema infants were characterized by a
higher abundance of the enterobacteria Klebsiella and Shi-
gella as well as Enterococcus, while Bifidobacterium
showed a higher abundance in non-eczema ones. These
last data are in general agreement with the intestinal
microbiota dysbioses observed in our study.
Although Bifidobacterium and Lactobacillus have been
traditionally indicated as possible protective factors
against atopic disease in childhood [16], we did not de-
tect any significant differences in these health-promoting
genera between atopics and controls, confirming previ-
ous findings reported by Penders et al. [3,18]. However,
molecular studies at the species level showed a different
distribution of the Bifidobacterium and Lactobacillus
species between allergic and non-allergic children
[36,38], suggesting a potential species-specific effect of
Table 3 qPCR quantification of F. prausnitzii, A.
muciniphila, Enterobacteriaceae, Clostridium cluster IV,
Bifidobacterium and Lactobacillus group in the faecal
microbiota of atopics and healthy controls
16S rRNA gene copies/μg fecal
DNA
Bacterial species/group Atopics Controls P value
Faecalibacterium prausnitzii 6.17E + 06 2.03E + 07 0.0014
Akkermansia muciniphila 3.01E + 05 5.03E + 05 0.0190
Enterobacteriaceae 3.86E + 04 1.19E + 04 0.3500
Clostridium cluster IV 4.46E + 06 1.55E + 07 0.0035
Bifidobacterium 1.08E + 06 1.72E + 06 0.0850
Lactobacillus group 3.75E + 02 5.48E + 02 0.6410
For each bacterial species/group, the mean 16S rRNA copy number per μg of
faecal DNA is reported.
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atopic disorders.
The atopy-related microbiota dysbioses we depicted in
our cohort of 19 children were independent of their pe-
culiar allergic profile. A subset of 10 atopics underwent
clinical evaluation of total IgE level and the correlation
between IgE and the relative abundance of specific mi-
crobial groups in the faeces was explored. Even if no sig-
nificant correlation was determined, L. casei et rel. and
Clostridium cluster IX tended to be negatively and posi-
tively correlated with IgE, respectively. Interestingly,
Ogawa et al. [39] demonstrated that orally administered
L. casei was effective in the control of the IgE levels in
human allergic reactions and, recently, Schiffer et al.
[40] reported that L. casei could inhibit the effector
phase of immune inflammation in vivo. Finally, Penders
et al. [38] showed a decreased risk of atopic dermatitis
in children colonized by L. paracasei, a member of the
L. casei et rel. group. Even if these studies may support
the tendency towards inverse correlation between L.
casei et rel. and IgE level we observed in our study,ρ = - 0.52
P = 0.100
Log IgE (ku/L) 
2.6 
2.8 




1.2 0.8 1.0 0.6 
Figure 3 Spearman rank correlation between total IgE level and the a
from a subset of 10 atopic children.caution must be taken in considering these data since
only a low number of children were analyzed.
Characterized by a decrease of the absolute levels of Clos-
tridium cluster IV, F. prausnitzii and A. muciniphila, as well
as a corresponding increase in the relative abundance of
Enterobacteriaceae, the atopy-associated intestinal micro-
bial community we described in this study is depleted in
key immunomodulatory members of the human intestinal
microbiota and possibly enriched in pro-inflammatory
“pathobionts” [41]. By the specific induction of T regs,
members of the Clostridium cluster IV have been demon-
strated to be strategic for maintaining the immune homeo-
stasis [42]. Analogously, providing a vast range of anti-
inflammatory effects, F. prausnitzii has been considered as
a crucial microorganism for gut homeostasis [43]. Finally,
A. muciniphila is a common member of the human intes-
tinal tract which has been recently associated with a pro-
tective/anti-inflammatory role in healthy gut [44]. On the
other hand, Enterobacteriaceae have been reported to pros-
per in the context of a host-mediated inflammatory re-
sponse [45]. Capable to venture more deeply in the mucus
layer and establish a close interaction with the epithelial
surface, members of Enterobacteriaceae concur in the in-
duction of a pro-inflammatory response and further con-
solidate the host inflammatory status. Thus, similarly to the
one characterized in IBD [43,46-48], the atopy-associated
microbiota can represent an inflammogenic microbial con-
sortium which can contribute to the severity of the disease
[7].
Conclusion
Atopic children were depleted in specific members of the
intestinal microbiota that, capable to orchestrate a broad
spectrum of inflammatory and regulatory T cell responses,
have been reported as fundamental for the immune
homeostasis. The decrease of these key immunomodulatory
symbionts in the gastrointestinal tract – as well as theρ = 0.60 
P = 0.073
Clostridium cluster IX 





Log IgE (ku/L) 
IF % 
bundance of L. casei et rel. and Clostridium cluster IX in the stools
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flammatory Enterobacteriaceae – support the immune de-
regulation and, in the context of an atopic host, can sustain
an inflammatory status throughout the body. Since the
atopy-related dysbioses of the intestinal microbiota can
contribute to the severity of the disease, atopy treatment
may be facilitated by redressing these microbiological unba-
lances. To this aim, advantages can be taken from the pos-
sibility to manipulate the microbiota plasticity with diet or
pharmaceutical prebiotics and probiotics. However, the
phylogenetic resolution of the data reported in our study
needs to be implemented by deep 16 S rDNA sequencing.
Moreover, metatranscriptomic studies can be carried out.
Linking the phylogenetic structure of the intestinal micro-
biota with its specific functional activities, the metatran-
scriptomic characterization of the intestinal microbiota in
atopic children could reveal the possible pathogenic
mechanisms behind the atopy-related microbiota dysbioses.Additional files
Additional file 1: Phylogenetically related groups target of the HTF-
Microbi.Array.
Additional file 2: Probe specificity tests for Akkermansia muciniphila.
Data refer to independent duplicates obtained using 50 fmol of purified
16 S rRNA PCR product. X axis shows the ZipCode for each probe pair; in
both figures, “1B” represents the ZipCode associated to A. muciniphila. Y
axis shows the average fluorescence intensities (IF) for each probe pair.
Fluorescence between the two replicates was not normalized. Blue stars
over the fluorescence bars indicate the probes that gave a positive
response with P <0.01. Red dots indicate that one or two replicates out
of four for each ZipCode were excluded because of having an IF 2.5-fold
above or below the average of the spots.
Additional file 3: HTF-Microbi.Array probe list. Sequences (5’ -> 3’) for
both discriminating (DS) and common probe (CP) are reported, as well as
major thermodynamic parameters [melting temperature (Tm), length
(bp), number of degenerated bases (Deg)].
Additional file 4: HTF-Microbi.Array raw fluorescence data obtained
from the analysis of faecal stools from 19 atopic children (A) and 12
healthy controls (C).
Additional file 5: Layout of the HTF-Microbi.Array and complete
ZipCode sequences.
Additional file 6: Box plots of the HTF-Microbi.Array fluorescence
signals from atopics and controls. P values corresponding to the
difference in fluorescence response between the two groups are
indicated for each probe.Abbreviations
A: Asthma; AD: Allergic Atopic Dermatitis; CMA: Cow’s Milk Allergy;
GPS: Grass Pollen Sensitization; HTF-Microbi.Array: High Taxonomic
Fingerprint-Microbi.Array; IBD: Inflammatory Bowel Diseases; IF: Fluorescence
Intensities; KOALA: Is (in Dutch) an acronym for Child Parent and health,
Lifestyle and Genetic constitution; LDR-UA: Ligase Detection Reaction-
Universal Array; OAS: Oral Allergy Syndrome; PCA: Principal Component
Analysis; PC1 2 and 3: Principal Components 1, 2 and 3; RC: Rhinitis.Acknowledgments
This work was funded by the Micro(bi)array project of the University of
Bologna, Italy. Our thanks to Giada Caredda for the support in experimental
phase.Author details
1Department of Pharmaceutical Sciences, University of Bologna, Via
Belmeloro 6, Bologna 40126, Italy. 2Institute of Biomedical Technologies,
Italian National Research Council, Milan, Italy. 3Paediatric Oncology and
Haematology Unit Lalla Seràgnoli, Sant’Orsola-Malpighi Hospital, University of
Bologna, Bologna, Italy. 4Department of Gynecological, Obstetrical and
Pediatric Sciences, Sant’Orsola-Malpighi Hospital, University of Bologna,
Bologna, Italy.
Authors’ contributions
MC conceived and designed the experiments, analyzed the data and wrote
the first draft of the paper. SR and ST performed faecal microbial DNA
extraction, 16 S rDNA amplification and purification, qPCR bacterial
quantifications and PCA analysis. MS, CC, GDB performed all the HTF-Microbi.
Array hybridization experiments and data analysis. RM, GR and AP enrolled
subjects and performed skin prick test and IgE determination. PB conceived
and designed the experiments. All authors read and approved the final
manuscript.
Received: 27 September 2011 Accepted: 6 June 2012
Published: 6 June 2012
References
1. Romagnani S: Regulatory T cells: which role in the pathogenesis and
treatment of allergic disorders? Allergy 2006, 61:3–14.
2. Ngoc PL, Gold DR, Tzianabos AO, Weiss ST, Celedón JC: Cytokines, allergy,
and asthma. Curr Opin Allergy Clin Immunol 2005, 5:161–166.
3. Penders J, Stobberingh EE, van den Brandt PA, Thijs C: The role of the
intestinal microbiota in the development of atopic disorders. Allergy
2007, 62:1223–1236.
4. Ehlers S, Kaufmann SH, Participants of the 99(th) Dahlem Conference:
Infection, inflammation, and chronic diseases: consequences of a
modern lifestyle. Trends Immunol 2010, 31:184–190.
5. Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E: The hygiene
hypothesis of atopic disease–an extended version. J Pediatr Gastroenterol
Nutr 2004, 38:378–388.
6. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S,
Collini S, Pieraccini G, Lionetti P: Impact of diet in shaping gut microbiota
revealed by a comparative study in children from Europe and rural
Africa. Proc Natl Acad Sci U S A 2010, 107:14691–14696.
7. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI: Human nutrition,
the gut microbiome and the immune system. Nature 2011, 474:327–336.
8. Lee YK, Mazmanian SK: Has the microbiota played a critical role in the
evolution of the adaptive immune system? Science 2010, 330:1768–1773.
9. Egert M, de Graaf AA, Smidt H, de Vos WM, Venema K: Beyond diversity:
functional microbiomics of the human colon. Trends Microbiol 2006,
14:86–91.
10. Mazmanian SK, Round JL, Kasper DL: A microbial symbiosis factor
prevents intestinal inflammatory disease. Nature 2008, 453:620–625.
11. Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, Mulder I, Lan A, Bridonneau C,
Rochet V, Pisi A, De Paepe M, Brandi G, Eberl G, Snel J, Kelly D, Cerf-
Bensussan N: The key role of segmented filamentous bacteria in the
coordinated maturation of gut helper T cell responses. Immunity 2009,
31:677–689.
12. Neish AS: Microbes in gastrointestinal health and disease.
Gastroenterology 2009, 136:65–80.
13. Maslowski KM, Mackay CR: Diet, gut microbiota and immune responses.
Nat Immunol 2011, 12:5–9.
14. Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F,
Adams H, van Ree R, Stobberingh EE: Gut microbiota composition and
development of atopic manifestations in infancy: the KOALA Birth
Cohort Study. Gut 2007, 56:661–667.
15. Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E: Distinct
patterns of neonatal gut microflora in infants in whom atopy was and
was not developing. J Allergy Clin Immunol 2001, 107:129–134.
16. Vael C, Desager K: The importance of the development of the intestinal
microbiota in infancy. Curr Opin Pediatr 2009, 21:794–800.
17. Murray CS, Tannock GW, Simon MA, Harmsen HJ, Welling GW, Custovic A,
Woodcock A: Fecal microbiota in sensitized wheezy and non-sensitized
non-wheezy children: a nested case–control study. Clin Exp Allergy 2005,
35:741–745.
Candela et al. BMC Microbiology 2012, 12:95 Page 9 of 9
http://www.biomedcentral.com/1471-2180/12/9518. Penders J, Stobberingh EE, Thijs C, Adams H, Vink C, van Ree R, van den
Brandt PA: Molecular fingerprinting of the intestinal microbiota of infants
in whom atopic eczema was or was not developing. Clin Exp Allergy 2006,
36:1602–1608.
19. Bisgaard H, Li N, Bonnelykke K, Chawes BL, Skov T, Paludan-Müller G,
Stokholm J, Smith B, Krogfelt KA: Reduced diversity of the intestinal
microbiota during infancy is associated with increased risk of allergic
disease at school age. J Allergy Clin Immunol 2011, 128:646–652.
20. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L,
Jenmalm MC: Low diversity of the gut microbiota in infants with atopic
eczema. J Allergy Clin Immunol 2012, 129:434–440.
21. Blaser MJ, Falkow S: What are the consequences of the disappearing
human microbiota? Nat Rev Microbiol 2009, 7:887–894.
22. Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R: Development of the
human gastrointestinal microbiota and insights from high-throughput
sequencing. Gastroenterology 2011, 140:1713–1719.
23. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO: Development of the
human infant intestinal microbiota. PLoS Biol 2007, 5:e177.
24. Candela M, Consolandi C, Severgnini M, Biagi E, Castiglioni B, Vitali B, De
Bellis G, Brigidi P: High taxonomic level fingerprint of the human
intestinal microbiota by ligase detection reaction–universal array
approach. BMC Microbiol 2010, 19:116.
25. Rajilić-Stojanović M, Smidt H, de Vos WM: Diversity of the human
gastrointestinal tract microbiota revisited. Environ Microbiol 2007,
9:2125–2136.
26. Dreborg S, Frew A: Position Paper EAACI: allergen standardization and
skin tests. Allergy 1993, 48:49–82.
27. Cavagni G, Capra T, Suzzani L, Nori G, Derin FM, Dusi R, Bernasconi S: Valori
di IgE in bambini sani, non atopici. Folia Allergol Immunol Clin 1980,
27:273.
28. Castiglioni B, Rizzi E, Frosini A, Sivonen K, Rajaniemi P, Rantala A, Mugnai
MA, Ventura S, Wilmotte A, Boutte C, Grubisic S, Balthasart P, Consolandi C,
Bordoni R, Mezzelani A, Battaglia C, De Bellis G: Development of a
universal microarray based on the ligation detection reaction and 16 S
rrna gene polymorphism to target diversity of cyanobacteria. Appl
Environ Microbiol 2004, 70:7161–7172.
29. Consolandi C, Severgnini M, Castiglioni B, Bordoni R, Frosini A, Battaglia C,
Rossi Bernardi L, De Bellis G: A structured chitosan-based platform for
biomolecule attachment to solid surfaces: application to DNA microarray
preparation. Bioconjug Chem 2006, 17:371–377.
30. Leps J, Smilauer P: Multivariate analysis of ecological data using CANOCO.
Cambridge: Cambridge University Press; 2003.
31. Collado MC, Derrien M, Isolauri E, de Vos WM, Salminem S: Intestinal
integrity and Akkermansia muciniphila, a mucin-degrading member of
the intestinal microbiota present in infants, adults and the elderly. Appl
Environ Microbiol 2007, 23:7767–7770.
32. Bartosch S, Fite A, Macfarlane GT, McMurdo MET: Characterization of
bacterial communities in feces from healthy elderly volunteers and
hospitalized elderly patients by using Real-Time PCR and effects of
antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 2004,
6:3575–3581.
33. Van Dyke MI, McCarthy AJ: Molecular biological detection and
characterization of Clostridium populations in municipal landfill sites.
Appl Environ Microbiol 2002, 4:2049–2053.
34. Kok RG, de Waal A, Schut F, Welling GW, Weenk G, Hellingwerf KJ: Specific
detection and analysis of a probiotic Bifidobacterium strain in infant
feces. Appl Environ Microbiol 1996, 62:3668–3672.
35. Walter J, Hertel C, Tannock GW, Lis CM, Munro K, Hammes WP: Detection
of Lactobacillus, Pediococcus, Leuconostoc and Weissella species in human
feces by using group-specific PCR primers and denaturing gradient gel
electrophoresis. Appl Environ Microbiol 2001, 67:2578–2585.
36. Stsepetova J, Sepp E, Julge K, Vaughan E, Mikelsaar M, de Vos WM:
Molecularly assessed shifts of Bifidobacterium ssp. and less diverse
microbial communities are characteristic of 5-year-old allergic children.
FEMS Immunol Med Microbiol 2007, 51:260–269.
37. Hong PY, Lee BW, Aw M, Shek LP, Yap GC, Chua KY, Liu WT: Comparative
analysis of fecal microbiota in infants with and without eczema.
PLoS One 2010, 5:e9964.
38. Penders J, Thijs C, Mommers M, Stobberingh EE, Dompeling E, Reijmerink
NE, van den Brandt PA, Kerkhof M, Koppelman GH, Postma DS: Intestinal
lactobacilli and the DC-SIGN gene for their recognition by dendritic cellsplay a role in the aetiology of allergic manifestations. Microbiology 2010,
156:3298–3305.
39. Ogawa T, Hashikawa S, Asai Y, Sakamoto H, Yasuda K, Makimura Y: A new
synbiotic, Lactobacillus casei subsp. casei together with dextran, reduces
murine and human allergic reaction. FEMS Immunol Med Microbiol 2006,
46:400–409.
40. Schiffer C, Lalanne AI, Cassard L, Mancardi DA, Malbec O, Bruhns P, Dif F,
Daëron M: A strain of Lactobacillus casei inhibits the effector phase of
immune inflammation. J Immunol 2011, 187:2646–2655.
41. Chow J, Mazmanian SK: A pathobiont of the microbiota balances
host colonization and intestinal inflammation. Cell Host Microbe 2010,
7:265–276.
42. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G,
Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki
Y, Itoh K, Honda K: Induction of colonic regulatory T cells by indigenous
Clostridium species. Science 2011, 331:337–341.
43. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG,
Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C,
Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau
P, Seksik P, Langella P: Faecalibacterium prausnitzii is an anti-inflammatory
commensal bacterium identified by gut microbiota analysis of Crohn
disease patients. Proc Natl Acad Sci U S A 2008, 105:16731–16736.
44. Png CW, Lindén SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI,
McGuckin MA, Florin TH: Mucolytic bacteria with increased prevalence in
IBD mucosa augment in vitro utilization of mucin by other bacteria. Am
J Gastroenterol 2010, 105:2420–2428.
45. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC,
Finlay BB: Host-mediated inflammation disrupts the intestinal microbiota
and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe
2007, 2:204.
46. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR:
Molecular-phylogenetic characterization of microbial community
imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U
S A 2007, 104:13780–13785.
47. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes
J, Corthier G, Marteau P, Doré J: Low counts of Faecalibacterium prausnitzii
in colitis microbiota. Inflamm Bowel Dis 2009, 15:1183–1189.
48. Schwiertz A, Jacobi M, Frick JS, Richter M, Rusch K, Köhler H: Microbiota in
pediatric inflammatory bowel disease. J Pediatr 2010, 157:240–244.
doi:10.1186/1471-2180-12-95
Cite this article as: Candela et al.: Unbalance of intestinal microbiota in
atopic children. BMC Microbiology 2012 12:95.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
